AIS
ANIK icon

Accurate Investment Solutions’s Anika Therapeutics ANIK Stock Holding History

Accurate Investment Solutions’s Portfolio ANIK Stock Details ANIK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-114
Closed -$5K – 360
2019
Q2 		$5K Buy
+114
New +$4.16K ﹤0.01% 266

Other funds holding ANIK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $12.2B AUM 12.45% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Accurate Investment Solutions's ANIK Position: Q3 2019 in Review

Accurate Investment Solutions sold out of Anika Therapeutics (ANIK) in Q3 2019, closing a stake of 114 shares — an estimated $5K sold.

Accurate Investment Solutions first reported a position in ANIK in Q2 2019 and held it in 1 quarter. The position peaked at $5K in Q2 2019. 194 funds tracked by Wall St. Rank hold ANIK as of Q3 2019.

  • Accurate Investment Solutions reported no remaining Anika Therapeutics position as of Q3 2019 after selling out during the quarter.
  • Accurate Investment Solutions sold 114 Anika Therapeutics shares in Q3 2019, an estimated $5K.
  • Accurate Investment Solutions first reported a position in Anika Therapeutics in Q2 2019 and held it in 1 quarter.
  • Accurate Investment Solutions's Anika Therapeutics position peaked at $5K in Q2 2019.
  • 194 funds tracked by Wall St. Rank held Anika Therapeutics as of Q3 2019.

Based on Accurate Investment Solutions's 13F filing for Q3 2019, filed 10 Oct 2019.